EI
TEVA icon

EDMP Inc’s Teva Pharmaceuticals TEVA Stock Holding History

EDMP Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,439
Closed -$2.7M – 55
2020
Q1 		$2.7M Buy
+50,439
New +$517K 2.39% 17
2018
Q4 		– Sell
-26,674
Closed -$575K – 57
2018
Q3 		$575K Sell
26,674
-1,110
-4% -$25.8K 0.54% 42
2018
Q2 		$676K Sell
27,784
-845
-3% -$17.2K 0.7% 35
2018
Q1 		$489K Sell
28,629
-565
-2% -$11K 0.48% 41
2017
Q4 		$644K Sell
29,194
-2,860
-9% -$43K 0.55% 39
2017
Q3 		$564K Sell
32,054
-60
-0.2% -$1.35K 0.51% 41
2017
Q2 		$1.07M Sell
32,114
-190
-0.6% -$5.88K 0.99% 33
2017
Q1 		$1.04M Sell
32,304
-100
-0.3% -$3.41K 0.93% 34
2016
Q4 		$1.18M Sell
32,404
-960
-3% -$38.3K 1.16% 30
2016
Q3 		$1.53M Sell
33,364
-1,498
-4% -$78.2K 1.47% 28
2016
Q2 		$1.75M Sell
34,862
-15,577
-31% -$829K 1.7% 25
2016
Q1 		$2.7M Sell
50,439
-2,740
-5% -$161K 2.58% 18
2015
Q4 		$3.49M Sell
53,179
-2,180
-4% -$135K 3.35% 7
2015
Q3 		$3.13M Sell
55,359
-113
-0.2% -$7.33K 3.18% 13
2015
Q2 		$3.28M Sell
55,472
-2,275
-4% -$140K 3.14% 16
2015
Q1 		$3.6M Sell
57,747
-350
-0.6% -$20.4K 3.31% 15
2014
Q4 		$3.34M Sell
58,097
-3,923
-6% -$219K 3.13% 15
2014
Q3 		$3.33M Sell
62,020
-3,350
-5% -$177K 3.13% 14
2014
Q2 		$3.43M Sell
65,370
-390
-0.6% -$19.9K 3.21% 15
2014
Q1 		$3.48M Sell
65,760
-150
-0.2% -$6.93K 3.21% 14
2013
Q4 		$2.64M Buy
65,910
+355
+0.5% +$14K 2.33% 20
2013
Q3 		$2.48M Buy
65,555
+1,651
+3% +$64.4K 2.5% 20
2013
Q2 		$2.5M Buy
+63,904
New +$2.49M 2.57% 17

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EDMP Inc's TEVA Position: Q2 2020 in Review

EDMP Inc sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 50,439 shares — an estimated $2.7M sold.

EDMP Inc first reported a position in TEVA in Q2 2013 and held it in 23 quarters. The position peaked at $3.6M in Q1 2015. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • EDMP Inc reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • EDMP Inc sold 50,439 Teva Pharmaceuticals shares in Q2 2020, an estimated $2.7M.
  • EDMP Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • EDMP Inc's Teva Pharmaceuticals position peaked at $3.6M in Q1 2015.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on EDMP Inc's 13F filing for Q2 2020, filed 20 Jul 2020.